Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary Tuberculosis

NMP Medical Research Institute

Status and phase: Completed; Phase 2

Conditions: Pulmonary Tuberculosis

Treatments: Drug: Anti-Tuberculosis Treatment

Study type: Interventional

Funder types: Other

Identifiers

NCT01242592

NMP/H/01

Details and patient eligibility

About

The purpose of the study is to evaluate the effect of homeopathy as an adjuvant to Anti tuberculosis treatment on sputum conversion, hematological, clinical sign and symptoms of relapsed Pulmonary TB.

Enrollment: 56 patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

relapse pulmonary tuberculosis patients with acid-fast bacilli smear positive by microscopy, using ZiehlNieelsen staining as recommended by WHO, unfit for DOTS -

Exclusion criteria

pregnancy, clinical sign of any concomitant disease such as diabetes mellitus, acute renal failure or infectious disease including TB/HIV and HIV positive, currently or taken any alternative therapies in past 6 months

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

56 participants in 2 patient groups, including a placebo group

Homeopathy

Experimental group

Treatment:

Drug: Anti-Tuberculosis Treatment

Placebo

Placebo Comparator group

Treatment:

Drug: Anti-Tuberculosis Treatment